Developer of microfluidic imaging platform designed to offer non-invasive genetic tests with diagnostic-level accuracy. The company's platform utilizes artificial intelligence to classify cells based on detailed visual features and isolates viable cells based on morphological distinctions, enabling researchers to eliminate the need for invasive diagnostic tests.